Mourits-Andersen T, Jensen R, Dyerberg J
Prostaglandins Leukot Med. 1986 Jun;22(3):335-48. doi: 10.1016/0262-1746(86)90144-7.
Some studies have recently reported increased production of platelet thromboxane and decreased vascular prostacyclin in patients with diabetes mellitus. The impact of these changes on platelet and vascular functions in vivo is still speculative. Using radio-immunoassay and high pressure liquid chromatography we have studied the plasma levels of 6-keto-PGF1 alpha, TXB2 and PGE2 in 23 juvenile-onset diabetics. There was no significant difference in these plasma prostaglandins between the diabetics and a control group. The prostaglandins were neither correlated to blood-glucose nor the degree of glycosylation (HbA1c). Our results can not support the hypothesis that decreased vascular prostacyclin and increased platelet production of TXB2 are important factors in diabetic patients.
最近一些研究报道,糖尿病患者体内血小板血栓素生成增加,血管前列环素生成减少。这些变化对体内血小板和血管功能的影响仍具有推测性。我们采用放射免疫分析法和高压液相色谱法,对23例青少年发病型糖尿病患者血浆中的6-酮-前列腺素F1α、血栓素B2和前列腺素E2水平进行了研究。糖尿病患者与对照组之间这些血浆前列腺素水平无显著差异。这些前列腺素与血糖及糖化程度(糖化血红蛋白A1c)均无相关性。我们的研究结果不支持以下假说,即血管前列环素减少和血小板血栓素B2生成增加是糖尿病患者的重要因素。